Skip to main content
Search hero banner

Search results

Showing 41 - 60 of 369 results

ansto-gentech-generator

Nuclear medicine processing and distribution

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

Leadership changes at ANSTO

This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.

Eugene Tan
Senior Accelerator Physicist

Role at ANSTO 

Woman standing next to accelerator transport line

Particle Accelerators

The Accelerator Science group purse a broad research program with the aims of improving the performance and reliability of our accelerators, increasing their research capabilities and developing the next generation of accelerator technology.

Safeguarding the future of nuclear medicine production

Safeguarding the future of Australia's nuclear medicine

The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.

Pagination